FDA Inspection 1090070 — ProCaire, LLC

ProCaire, LLC — FEI 3014721008

The FDA completed an inspection of ProCaire, LLC on May 17, 2019 in Plainville, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 6 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 17, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Plainville, MA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
119421 CFR 211.42(c)Defined areas of adequate size for operations
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
126321 CFR 211.68(b)Computer control of master formula records
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
202021 CFR 211.188(b)(8)Labeling Control Records and Label Copies